Quanterix (NASDAQ:QTRX) Issues Earnings Results

Quanterix (NASDAQ:QTRX) released its quarterly earnings results on Monday. The company reported ($0.30) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03), Zacks reports. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. The firm had revenue of $35.16 million for the quarter, compared to analysts’ expectations of $34.93 million. Quanterix updated its FY 2025 guidance to EPS.

Quanterix Price Performance

Shares of NASDAQ:QTRX opened at $7.15 on Wednesday. Quanterix has a 1 year low of $6.30 and a 1 year high of $27.37. The company has a market cap of $275.45 million, a PE ratio of -6.75 and a beta of 1.34. The stock’s 50-day moving average is $8.41 and its 200 day moving average is $10.93.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group decreased their price objective on Quanterix from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.